what is the difference in semaglutide and wegovy vs. Ozempic: Important Differences To Consider Ozempic vs. Wegovy: What's the

The prior 2017 FDA guidance also indicates, Unlike for BCS class 1 products, for a biowaiver to be scientifically justified, BCS class 3 test drug product must contain the same excipients as the reference product, and further describes evaluation of the same excipients (e.g., qualitatively the same and quantitatively similar)

But experts warn that its not a silver bullet

Potential side effects include mild injection site reactions, headache, flushing, water retention, or tingling sensations

CLINICAL RECOMMENDATION FOR PRESCRIBERS: GLP-1 medication labels do not currently include a warning for the risk of triggering restrictive eating disorders